A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement
NCT ID: NCT00351793
Last Updated: 2022-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
186 participants
OBSERVATIONAL
2003-01-31
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty
NCT00853398
Prospective Functional Outcome Study of the Knee
NCT02079493
Roentgen Stereophotogrammetric Analysis (RSA) to Evaluate Fixation of Biofoam Advance Total Knee Arthroplasty Components
NCT00657956
Fully Disposable Patient-Specific Instrumentation
NCT02966613
A Study to Evaluate the Safety of Augment™ Bone Graft
NCT01290991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined Deformity <30 degrees
Knee Implant
Total knee replacement with Genesis II posterior stabilized knee
Combined Deformity >30 degrees
Knee Implant
Total knee replacement with Genesis II posterior stabilized knee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Knee Implant
Total knee replacement with Genesis II posterior stabilized knee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A combined deformity of \>30 degrees = group 2
* Patient is willing to consent to participate in the study
* Patient is available for follow-up through at least 2 years but preferably 5 years
* Patient has met acceptable preoperative medical clearance and is free of or treated for medical conditions that would pose excessive operative risk
* Patients who are fluent in English and are able to understand their role in a clinical trial
Exclusion Criteria
* Fibromyalgia patients
* Patients whom, as judged by the surgeon, are not capable of understanding the informed consent or the requirements of the protocol and or are reasonably unlikely to be compliant with the prescribed routine and the follow-up evaluation schedule
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Ross Leighton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ross Leighton
Orthopedic Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ross K Leighton, MD, FRCS(C)
Role: PRINCIPAL_INVESTIGATOR
Capital Health, Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-RL-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.